OCM
BMY icon

Ovata Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Ovata Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-306,302
Closed -$689K – 52
2020
Q3 		$689K Buy
306,302
+174,625
+133% +$10.5M 0.25% 39
2020
Q2 		$471K Buy
+131,677
New +$7.88M 0.14% 42

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ovata Capital Management's BMY Position: Q4 2020 in Review

Ovata Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 306,302 shares — an estimated $689K sold.

Ovata Capital Management first reported a position in BMY in Q2 2020 and held it in 2 quarters. The position peaked at $689K in Q3 2020. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Ovata Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • Ovata Capital Management sold 306,302 Bristol-Myers Squibb shares in Q4 2020, an estimated $689K.
  • Ovata Capital Management first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 2 quarters.
  • Ovata Capital Management's Bristol-Myers Squibb position peaked at $689K in Q3 2020.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Ovata Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.